Vetoquinol SA (EPA: VETO)
France
· Delayed Price · Currency is EUR
78.90
-1.60 (-1.99%)
Nov 20, 2024, 5:35 PM CET
Vetoquinol Revenue
Vetoquinol had revenue of 264.44M EUR in the half year ending June 30, 2024, a decrease of -2.34%. This brings the company's revenue in the last twelve months to 537.47M, up 2.32% year-over-year. In the year 2023, Vetoquinol had annual revenue of 529.27M, down -1.95%.
Revenue (ttm)
537.47M
Revenue Growth
+2.32%
P/S Ratio
1.74
Revenue / Employee
213.37K
Employees
2,440
Market Cap
933.59M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 529.27M | -10.51M | -1.95% |
Dec 31, 2022 | 539.78M | 18.51M | 3.55% |
Dec 31, 2021 | 521.27M | 93.81M | 21.94% |
Dec 31, 2020 | 427.47M | 31.48M | 7.95% |
Dec 31, 2019 | 395.99M | 28.05M | 7.62% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech S.A. | 2.74B |
bioMérieux S.A. | 3.81B |
Ipsen S.A. | 3.44B |
Eurofins Scientific SE | 6.72B |
Virbac SA | 1.34B |
Ramsay Générale de Santé SA | 5.01B |